Author details

Full Name

Jamie P Dwyer

Affiliation

University of Utah Health

ORCID

Career Start Year

2005

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37632201	Efficacy and safety of zibotentan and dapagliflozin in patients with chronic kidney disease: study design and baseline characteristics of the ZENITH-CKD trial.	Nephrol Dial Transplant	2024
37004812	Concordance between clinical outcomes in the Systolic Blood Pressure Intervention Trial and in the electronic health record.	Contemp Clin Trials	2023
37556796	Risk Assessment of Kidney Disease Progression and Efficacy of SGLT2 Inhibition in Patients With Type 2 Diabetes.	Diabetes Care	2023
37654775	Decentralized clinical trials in the trial innovation network: Value, strategies, and lessons learned.	J Clin Transl Sci	2023
37606716	Impact of Sodium Zirconium Cyclosilicate Plus Renin-Angiotensin-Aldosterone System Inhibitor Therapy on Short-Term Medical Costs in Hyperkalemia: OPTIMIZEÂ II Real-World Study.	Adv Ther	2023
37540162	Short-term costs in patients with chronic kidney disease treated with dapagliflozin: a retrospective cohort study.	Expert Rev Pharmacoecon Outcomes Res	2023
35597321	New Directions in Phosphorus Management in Dialysis.	J Ren Nutr	2023
34560136	A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function.	Kidney Int	2022
36139492	Diabetic Proteinuria Revisited: Updated Physiologic Perspectives.	Cells	2022
35997319	Dapagliflozin and Prevention of Kidney Disease Among Patients With Type 2 Diabetes: Post Hoc Analyses From the DECLARE-TIMI 58 Trial.	Diabetes Care	2022
35919535	Effect of Intensive versus Standard BP Control on AKI and Subsequent Cardiovascular Outcomes and Mortality: Findings from the SPRINT EHR Study.	Kidney360	2022
35058294	Antihypertensive drug effects on long-term blood pressure: an individual-level data meta-analysis of randomised clinical trials.	Heart	2022
34403831	Multinephron Segment Diuretic Therapy to Overcome Diuretic Resistance in Acute Heart Failure: A Single-Center Experience.	J Card Fail	2022
33200891	Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease.	N Engl J Med	2021
36751533	Anti-Phospholipase A2 Receptor in Nonlupus Patients with Membranous Nephropathy and Crescents.	Glomerular Dis	2021
33851953	Effect of Dapagliflozin on Cardiovascular Outcomes According to Baseline Kidney Function and Albuminuria Status in Patients With Type 2 Diabetes: A Prespecified Secondary Analysis of a Randomized Clinical Trial.	JAMA Cardiol	2021
34233928	The Effect of Dapagliflozin on Albuminuria in DECLARE-TIMI 58.	Diabetes Care	2021
32245780	COVID-19 and the Inpatient Dialysis Unit: Managing Resources during Contingency Planning Pre-Crisis.	Clin J Am Soc Nephrol	2020
33044494	Concordance Between Blood Pressure in the Systolic Blood Pressure Intervention Trial and in Routine Clinical Practice.	JAMA Intern Med	2020
30586726	Lorcaserin and Renal Outcomes in Obese and Overweight Patients in the CAMELLIA-TIMI 61 Trial.	Circulation	2019
31324734	Implications of Early Decline in eGFR due to Intensive BP Control for Cardiovascular Outcomes in SPRINT.	J Am Soc Nephrol	2019
31196815	Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE-TIMI 58 randomised trial.	Lancet Diabetes Endocrinol	2019
31023452	Assessment of Blood Pressure: Techniques and Implications From Clinical Trials.	Adv Chronic Kidney Dis	2019
30786196	Plazomicin for Infections Caused by Carbapenem-Resistant Enterobacteriaceae.	N Engl J Med	2019
30786187	Once-Daily Plazomicin for Complicated Urinary Tract Infections.	N Engl J Med	2019
29162340	Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT).	Am J Kidney Dis	2018
30256784	Pulse wave velocity and central aortic pressure in systolic blood pressure intervention trial participants.	PLoS One	2018
30293771	Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial.	Lancet	2018
29526502	Efficacy and safety of lipid lowering by alirocumab in chronic kidney disease.	Kidney Int	2018
29712745	Impact of Intensive Versus Standard Blood Pressure Management by Tertiles of Blood Pressure in SPRINT (Systolic Blood Pressure Intervention Trial).	Hypertension	2018
27615161	Adherence rates to ferric citrate as compared to active control in patients with end stage kidney disease on dialysis.	Hemodial Int	2017
28128726	The safety of achieved iron stores and their effect on IV iron and ESA use: post-hoc results from a randomized trial of ferric citrate as a phosphate binder in dialysisâ¿©.	Clin Nephrol	2017
28923834	Is Chronic Dialysis the Right Hard Renal End Point To Evaluate Renoprotective Drug Effects?	Clin J Am Soc Nephrol	2017
27849563	Effect of Intensive Versus Standard Clinic-Based Hypertension Management on Ambulatory Blood Pressure: Results From the SPRINT (Systolic Blood Pressure Intervention Trial) Ambulatory Blood Pressure Study.	Hypertension	2017
26865200	Patterns and Correlates of Baseline Thiazide-Type Diuretic Prescription in the Systolic Blood Pressure Intervention Trial.	Hypertension	2016
26434564	Early renin-angiotensin system intervention is more beneficial than late intervention in delaying end-stage renal disease in patients with type 2 diabetes.	Diabetes Obes Metab	2016
27153768	We Give Too Much Intravenous Iron.	Semin Dial	2016
27337598	Individualized prediction of the effect of angiotensin receptor blockade on renal and cardiovascular outcomes in patients with diabetic nephropathy.	Diabetes Obes Metab	2016
25060056	Ferric citrate controls phosphorus and delivers iron in patients on dialysis.	J Am Soc Nephrol	2015
26239948	Ferric Citrate, an Iron-Based Phosphate Binder, Reduces Health Care Costs in Patients on Dialysis Based on Randomized Clinical Trial Data.	Drugs R D	2015
25958079	The Phosphate Binder Ferric Citrate and Mineral Metabolism and Inflammatory Markers in Maintenance Dialysis Patients: Results From Prespecified Analyses of a Randomized Clinical Trial.	Am J Kidney Dis	2015
25736045	Ferric Citrate Reduces Intravenous Iron and Erythropoiesis-Stimulating Agent Use in ESRD.	J Am Soc Nephrol	2015
25759700	Kidney dysfunction and left ventricular assist device support: a comprehensive perioperative review.	Cardiorenal Med	2015
25495878	Phosphorus binding with ferric citrate is associated with fewer hospitalizations and reduced hospitalization costs.	Expert Rev Pharmacoecon Outcomes Res	2015
25532068	Pyridoxamine dihydrochloride in diabetic nephropathy (PIONEER-CSG-17): lessons learned from a pilot study.	Nephron	2015
24210590	Estimated GFR decline as a surrogate end point for kidney failure: a post hoc analysis from the Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan (RENAAL) study and Irbesartan Diabetic Nephropathy Trial (IDNT).	Am J Kidney Dis	2014
25242077	Ferric citrate spans mineral metabolism and anemia domains in ESRD: a review of efficacy and safety data.	Expert Rev Clin Pharmacol	2014
25069689	Does renal dysfunction and method of bridging support influence heart transplant graft survival?	Ann Thorac Surg	2014
25064674	Visit-to-visit variability in blood pressure and kidney and cardiovascular outcomes in patients with type 2 diabetes and nephropathy: a post hoc analysis from the RENAAL study and the Irbesartan Diabetic Nephropathy Trial.	Am J Kidney Dis	2014
24602469	Optimizing blood pressure control in patients with nondiabetic glomerular disease.	Adv Chronic Kidney Dis	2014

1 - 50 of 75

Negiin Pourafshar

MedStar Georgetown University Hospital

Career Start Year 2015

Number of shared co-authors 0

John Schollum

Dunedin School of Medicine, University of Otago

Career Start Year 2008

Number of shared co-authors 0

John Danziger

Beth Israel Deaconess Medical Center, Harvard Medical School

Career Start Year 2008

Number of shared co-authors 1

Sankar D Navaneethan

Selzman Institute for Kidney Health, Baylor College of Medicine

Career Start Year 2004

Number of shared co-authors 6

Antonio Bellasi

Universita della Svizzera Italiana (USI)

Career Start Year 2003

Number of shared co-authors 1

Nisha Bansal

Kidney Research Institute, University of Washington

Career Start Year 2003

Number of shared co-authors 8

Amir Kazory

University of Florida

Career Start Year 2003

Number of shared co-authors 2

Steven M Brunelli

DaVita Clinical Research

Career Start Year 2002

Number of shared co-authors 3

Amit X Garg

Western University

Career Start Year 2001

Number of shared co-authors 6

Robert C Albright

Mayo Clinic

Career Start Year 2000

Number of shared co-authors 0

Uptal D Patel

Duke University

Career Start Year 2000

Number of shared co-authors 4

Ladan Golestaneh

Montefiore Medical Center and Albert Einstein College of Medicine

Career Start Year 1999

Number of shared co-authors 0

Gearoid M McMahon

Brigham and Women's Hospital, MA Harvard Medical School

Career Start Year 1999

Number of shared co-authors 0

Rajesh Mohandas

LSU Health New Orleans School of Medicine

Career Start Year 1999

Number of shared co-authors 0

Anitha Vijayan

Washington University in St. Louis.

Career Start Year 1998

Number of shared co-authors 1

Lynda A Szczech

FibroGen Inc.

Career Start Year 1997

Number of shared co-authors 0

Robert MacGinley

Eastern Health Clinical School, Monash University

Career Start Year 1997

Number of shared co-authors 0

Matthew A Weir

Western University

Career Start Year 1996

Number of shared co-authors 0

Sushrut S Waikar

Boston University Chobanian & Avedisian School of Medicine, Boston Medical Center

Career Start Year 1995

Number of shared co-authors 7

Abutaleb A Ejaz

University of Maryland School of Medicine

Career Start Year 1994

Number of shared co-authors 0

Andrew A House

The Lilibeth Caberto Kidney Clinical Research Unit, Western University

Career Start Year 1993

Number of shared co-authors 3

Peter A McCullough

Truth for Health Foundation

Career Start Year 1992

Number of shared co-authors 10

Jonathan Himmelfarb

Kidney Research Institute and Division of Nephrology, University of Washington

Career Start Year 1990

Number of shared co-authors 6

Rakesh Malhotra

University of California San Diego

Career Start Year 1989

Number of shared co-authors 4

Mitchell H Rosner

University of Virginia Health

Career Start Year 1987

Number of shared co-authors 1

Edward A Ross

University of Central Florida

Career Start Year 1986

Number of shared co-authors 0

Paul M Palevsky

University of Pittsburgh School of Medicine

Career Start Year 1984

Number of shared co-authors 5

Michael J Germain

Baystate Medical Center-University of Massachusetts Springfield

Career Start Year 1982

Number of shared co-authors 1

Vinod Bansal

Mayo Clinic

Career Start Year 1978

Number of shared co-authors 0

Francis P Wilson

Clinical and Translational Research Accelerator, Yale University School of Medicine

Career Start Year 1949

Number of shared co-authors 7

row(s) 1 - 30 of 30

Julia B Lewis

Vanderbilt University Medical Center

Co-authored papers 26

Marc S Sabatine

Brigham and Women's Hospital

Co-authored papers 7

Deepak L Bhatt

Icahn School of Medicine at Mount Sinai Health System

Co-authored papers 6

James P Lash

Co-authored papers 5

Benjamin M Scirica

Brigham and Women's Hospital

Co-authored papers 4

Barry I Freedman

Co-authored papers 2

Mary E Keebler

Co-authored papers 2

Mikhail Kosiborod

Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City

Co-authored papers 2

David Z I Cherney

University Health Network, University of Toronto

Co-authored papers 2

Christopher P Cannon

Brigham and Women's Hospital

Co-authored papers 2

Edward D Siew

Vanderbilt O'Brien Center for Kidney Disease, Vanderbilt University Medical Center

Co-authored papers 2

Walter T Ambrosius

Wake Forest School of Medicine

Co-authored papers 2

Talat Alp Ikizler

Vanderbilt University Medical Center

Co-authored papers 2

Balaji Athreya

Co-authored papers 1

Josh F Peterson

Vanderbilt University Medical Center

Co-authored papers 1

Lee M Kaplan

Co-authored papers 1

Michael Matheny

American College of Medical Informatics, Department of Veteran Affairs, Harvard University T H Chan School of Public Health, Massachusetts Institute of Technology, The American Society for Clinical Investigation, University of Kentucky, Vanderbilt University Medical Center, Vanderbilt University Medical School

Co-authored papers 1

Christianne L Roumie

Vanderbilt University Medical Center

Co-authored papers 1

Jonathan S Schildcrout

Vanderbilt University Medical Center.

Co-authored papers 1

Ioana Danciu

Oak Ridge National Laboratory

Co-authored papers 1

Renato D Lopes

Duke Clinical Research Institute, Duke University